Market Research Logo

Specialty Enzymes Market by Types (Acylases, Hydratases, Humulin, Oxidase, Lyases, Restriction enzymes, Ligases, Polymerases, Lipases, Amylases, Proteases, Dehydrogenases, Glucouronidse) and By Source (Microorganisms, Plants, Animals) - Global Opportunity

Specialty enzymes have gained popularity in the recent years owing to their potential applications in various industries such as pharmaceutical, biotechnology research and diagnostics. Specialty enzymes are proteins that act as biocatalysts to accelerate reactions and produce the desired results in pharmaceuticals and diagnostics reactions. In the pharmaceuticals industry, specialty enzymes play a major role in drug formulation and drug delivery. Enzyme based pharmaceutical drug formulations are used for the treatment of chronic conditions such as cancer and AIDS. Specialty enzymes have been widely used in the biotechnology industry for research, particularly in the molecular biology. They are also used in genetic engineering techniques to cut, replicate and attach DNA as per requirement. Specialty enzymes play a major role in the diagnosis of diseases such as cancer, cardiovascular diseases and lysosomal disorders. The specialty enzymes required for diagnostics has to be of the highest purity and in small quantity, which results in the high cost and less adoption of diagnostic enzymes.

The increasing applications of enzymes in therapies for chronic diseases, rising demand for effective therapeutics and growing incidences of digestive enzyme disorders are some of the key factors that drive the growth of the global specialty enzymes market for pharmaceuticals, biotechnology research and diagnostics. Factors restraining the market growth are restriction concerning the chemical properties and safety issues arising due to the contamination of enzymes. The global specialty enzymes market for pharmaceuticals, biotechnology research and diagnostics accounted for $561.9 million in 2014 and is forecast to generate $947.5 million by 2020, registering a CAGR of 9.4% during 2015 - 2020.

The global specialty enzymes for pharmaceuticals, biotechnology R&D and diagnostics market is segmented based on the application, source, type and geography. Based on the applications, the market is segmented into pharmaceuticals, biotechnology R&D and diagnostics. Based on the source, the market is segmented into three types, namely microorganisms, plants and animals. The microorganisms segment held a dominant share in the market in 2014 owing to its easy availability, feasibility for large scale production and cost-effectiveness. Microorganisms are easier to cultivate and the quantity of enzyme production can be controlled and estimated. Based on the product type, the market is segmented into acylases, hydratases, humulin, oxidase, lyases, restriction enzymes, ligases, polymerases, lipases, amylases, proteases, dehydrogenases, glucuronidase and others. Acylases enzyme held a dominant share of the market in 2014 owing to its wide and diversified application in the pharmaceutical drug formulations.

Geographically, the specialty enzyme market is segmented into North America, Europe, Asia-Pacific and LAMEA regions. North America region had the largest market for the specialty enzymes in 2014 due to the presence of large number of biopharmaceutical companies in the U.S. and favorable government regulations. High prevalence rates of digestive disorders would also fuel the demand for the digestive aids and supplements in the North America specialty enzymes market. The key companies profiled in this report include, Novozymes, DuPont, F. Hoffmann-La Roche AG, BASF, Life technologies, Advance enzyme Technologies Ltd, Affymetrix, Inc., and Codexis, Inc.

KEY MARKET BENEFITS:

    The report provides a quantitative analysis of the current market estimations during the period of 2014–2020, which would enable the stakeholders to capitalize on prevailing market opportunities
    Extensive analysis of the global specialty enzymes market by type helps in understanding the types of enzymes that are currently used along with the variants that would gain prominence in future
    Competitive intelligence highlights the business practices followed by leading market players across various geographies
    Comprehensive analysis of factors that drive and restrict the growth of the global specialty enzymes market has been provided
    SWOT analysis highlights the internal environment of leading companies for effective strategy formulation
    The specialty enzymes market scenario has been comprehensively analyzed in accordance to the key regions

KEY MARKET SEGMENTS:
The specialty enzymes market is segmented as below:

    Global Specialty Enzymes Market - By Application
        Pharmaceutical
        Biotechnology R&D
        Diagnostic
    Global Specialty Enzymes Market - By Source
        Microorganisms
        Plants
        Animals
    Global Specialty Enzymes Market - By Type
        Acylases
        Hydratases
        Humulin
        Oxidase
        Lyases
        Restriction enzymes
        Ligases
        Polymerases
        Lipases
        Amylases
        Proteases
        Dehydrogenases
        Glucouronidse
        Others
    Global Specialty Enzymes Market - By Geography
        North America
        Europe
        Asia-Pacific
        LAMEA


CHAPTER 1 INTRODUCTION
1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research Methodology
1.4.1 Primary research
1.4.2 Secondary research
1.4.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY
2.1 CXO perspective
2.2 Market beyond what to expect by 2025 ($Million)
2.2.1 Moderate growth scenario
2.2.2 Rapid growth scenario
2.2.3 Diminishing growth scenario

CHAPTER 3 MARKET OVERVIEW
3.1 Market definition and scope
3.2 Enzyme extraction processes
3.2.1 Filtration
3.2.2 Centrifugation and sedimentation:
3.2.3 Purification:
3.3 Key findings
3.3.1 Top impacting factors
3.3.2 Top investment pockets
3.3.3 Top winning strategies
3.4 Government regulations
3.5 Value chain analysis
3.5.1.1 Primary Activities
3.5.1.2 Supportive Activities
3.6 Market share analysis, 2014
3.7 Clinical trials
3.8 Patent analysis (2010-2014)
3.8.1 Patent analysis by geographies (2010-2014)
3.8.2 Patent analysis by sub segment (2010-2014)
3.9 Market dynamics
3.9.1 Drivers
3.9.2 Restraints
3.9.3 Opportunities

CHAPTER 4 GLOBAL SPECIALTY ENZYMES FOR PHARMACEUTICALS, BIOTECH R&D AND DIAGNOSTICS MARKET, BY APPLICATION 2014-2020,
4.1 Pharmaceuticals
4.1.1 Key market trends
4.1.2 Market growth factors and opportunities
4.1.3 Market size and forecast
4.2 Biotechnology research and development
4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast
4.3 Diagnostics
4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast

CHAPTER 5 GLOBAL SPECIALTY ENZYMES FOR PHARMACEUTICALS, BIOTECH R&D AND DIAGNOSTICS MARKET BY SOURCE, 2014-2020,
5.1 Microorganisms
5.1.1 Key market trends
5.1.2 Market growth factors and opportunities
5.1.3 Market size and forecast
5.2 Plants
5.2.1 Key market trends
5.2.2 Market growth factors and opportunities
5.2.3 Market size and forecast
5.3 Animal
5.3.1 Key market trends
5.3.2 Market growth factors and opportunities
5.3.3 Market size and forecast

CHAPTER 6 GLOBAL SPECIALTY ENZYMES FOR PHARMACEUTICALS, BIOTECH R&D AND DIAGNOSTICS MARKET BY TYPE, 2014-2020,
6.1 Overview
6.1.1 Market size and forecast
6.2 Acylases
6.2.1 Market size and forecast
6.3 Hydratases
6.3.1 Market size and forecast
6.4 Humulin
6.4.1 Market size and forecast
6.5 Oxidase
6.5.1 Market size and forecast
6.6 Lyases
6.6.1 Market size and forecast
6.7 Restriction enzymes
6.7.1 Market size and forecast
6.8 Ligases
6.8.1 Market size and forecast
6.9 Polymerases
6.9.1 Market size and forecast
6.10 Lipases
6.10.1 Market size and forecast
6.11 Amylases
6.11.1 Market size and forecast
6.12 Proteases
6.12.1 Market size and forecast
6.13 Dehydrogenases
6.13.1 Market size and forecast
6.14 Glucuronidases
6.14.1 Market size and forecast
6.15 Others
6.15.1 Market size and forecast

CHAPTER 7 GLOBAL SPECIALTY ENZYMES FOR PHARMACEUTICALS, BIOTECH R&D AND DIAGNOSTICS MARKET BY GEOGRAPHY, 2014-2020,
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key market trends
7.2.2 Competitive scenario
7.2.3 Key growth factors and opportunities
7.2.4 Market size and forecast
7.3 Europe
7.3.1 Key market trends
7.3.2 Competitive scenario
7.3.3 Key growth factors and opportunities
7.3.4 Market size and forecast
7.4 Asia-Pacific
7.4.1 Key market trends
7.4.2 Competitive scenario
7.4.3 Key growth factors and opportunities
7.4.4 Market size and forecast
7.5 LAMEA
7.5.1 Key market trends
7.5.2 Competitive scenario
7.5.3 Key growth factors and opportunities
7.5.4 Market size

TABLE 1 MODERATE GROWTH SCENARIO OF GLOBAL SPECIALTY ENZYMES MARKET, BY GEOGRAPHY, 2020-2025, ($MILLION)
TABLE 2 RAPID GROWTH SCENARIO OF GLOBAL SPECIALTY ENZYMES MARKET, BY GEOGRAPHY, 2020-2025, ($MILLION)
TABLE 3 DIMINISHING GROWTH SCENARIO OF GLOBAL SPECIALTY ENZYMES MARKET, BY GEOGRAPHY, 2020-2025, ($MILLION)
TABLE 4 CLINICAL TRIALS
TABLE 5 TYPES OF ENZYMES AND ITS APPLICATION
TABLE 6 ENZYMES GRADE SYSTEM
TABLE 7 GLOBAL SPECIALTY ENZYMES MARKET BY APPLICATION, 2014-2020, ($MILLION)
TABLE 8 GLOBAL PHARMACEUTICALS SPECIALTY ENZYMES MARKET BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 9 GLOBAL BIOTECH R&D SPECIALTY ENZYMES MARKET BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 10 GLOBAL DIAGNOSTICS SPECIALTY ENZYMES MARKET BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 11 GLOBAL SPECIALTY ENZYME MARKET, BY SOURCE, 2014-2020, ($MILLION)
TABLE 12 TYPES OF COMMERCIAL ENZYMES AND ITS SOURCE
TABLE 13 GLOBAL MICROORGANISMS DERIVED SPECIALTY ENZYMES MARKET BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 14 GLOBAL PLANT DERIVED SPECIALTY ENZYMES MARKET BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 15 GLOBAL ANIMAL DERIVED SPECIALTY ENZYMES MARKET BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 16 GLOBAL SPECIALTY ENZYMES MARKET BY TYPES, 2014-2020 ($MILLION)
TABLE 17 GLOBAL ACYLASES ENZYME MARKET, BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 18 GLOBAL HYDRATASES ENZYME MARKET, BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 19 GLOBAL HUMULIN ENZYME MARKET, BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 20 GLOBAL OXIDASE ENZYME MARKET, BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 21 GLOBAL LYASES ENZYME MARKET, BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 22 GLOBAL RETRICTION ENZYMES MARKET, BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 23 GLOBAL LIGASES ENZYME MARKET, BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 24 GLOBAL POLYMERASES ENZYME MARKET, BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 25 GLOBAL LIPASES ENZYME MARKET, BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 26 GLOBAL AMYLASES ENZYME MARKET, BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 27 GLOBAL PROTEASES ENZYME MARKET, BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 28 GLOBAL DEHYDROGENASES ENZYME MARKET, BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 29 GLOBAL GLUCURONIDASES ENZYME MARKET, BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 30 GLOBAL OTHER ENZYMES MARKET, BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 31 GLOBALSPECIALTY ENZYMES MARKET BY GEOGRAPHY, 2014-2020
TABLE 32 NORTH AMERICAN SPECIALTY ENZYMES MARKET, BY APPLICATION, 2014-2020, ($MILLION)
TABLE 33 EUROPE

FIG. 1 MODERATE GROWTH SCENARIO OF GLOBAL SPECIALTY ENZYMES MARKET, BY GEOGRAPHY, 2020-2025, ($MILLION)
FIG. 2 RAPID GROWTH SCENARIO OF GLOBAL SPECIALTY ENZYMES MARKET, BY GEOGRAPHY, 2020-2025, ($MILLION)
FIG. 3 DIMINISHING GROWTH SCENARIO OF GLOBAL SPECIALTY ENZYMES MARKET, BY GEOGRAPHY, 2020-2025, ($MILLION)
FIG. 4 TOP FACTORS IMPACTING GLOBAL SPECIALTY ENZYMES MARKET (2014-2020)
FIG. 5 TOP INVESTMENT POCKETS OF GLOBAL SPECIALTY ENZYMES MARKET
FIG. 6 TOP WINNING STRATEGIES IN SPECIALTY ENZYMES MARKET DURING 2010-2014
FIG. 7 VALUE CHAIN FOR SPECIALTY ENZYMES INDUSTRY
FIG. 8 MARKET SHARE ANALYSIS, 2014
FIG. 9 PATENT ANALYSIS BY GEOGRAPHIES (2010-2014)
FIG. 10 PATENT ANALYSIS BY SUB SEGMENT
FIG. 11 ROCHE REVENUE BY SEGMENT (2014)
FIG. 12 ROCHE HOLDING AG’S REVENUE BY REGION (2014)
FIG. 13 SWOT ANALYSIS OF ROCHE HOLDING AG.
FIG. 14 SANOFI  SA’S REVENUE BY BUSINESS SEGMENTS (2014)
FIG. 15 SWOT ANALYSIS OF SANOFI S.A.
FIG. 16 BASF REVENUE BY GEOGRAPHY (2014)
FIG. 17 BASF REVENUE BY SEGMENTS (2014)
FIG. 18 SWOT ANALYSIS OF BASF
FIG. 19 ADVANCED ENZYMES TECHNOLOGIES REVENUE (2011-2013)
FIG. 20 ADVANCED ENZYMES TECHNOLOGIES REVENUE BY GEOGRAPHY
FIG. 21 SWOT ANALYSIS OF BBI ENZYMES LTD.
FIG. 22 AFFYMETRIX REVENUE $MILLION (2012- 2014)
FIG. 23 SWOT ANALYSIS OF AFFYMETRIX
FIG. 24 CODEXIS REVENUE $MILLION (2012-2014)
FIG. 25 SWOT ANALYSIS OF CODEXIS INC.
FIG. 26 NOVOZYMES REVENUE $MILLION (2012-2014)
FIG. 27 NOVOZYME REVENUE BY SEGMENT
FIG. 28 NOVOZYME REVENUE BY GEOGRAPHY
FIG. 29 SWOT ANALYSIS OF NOVOZYMES
FIG. 30 FINANCIAL REVENUE OF DUPONT BY BUSINESS SEGMENT (2014)
FIG. 31 SWOT ANALYSIS OF DUPONT
FIG. 32 SWOT ANALYSIS OF AB ENZYMES



Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report